She feared for her life every day for three years. “It was extremely depressing,” said Suki. “Everyone wants to see their ...
Despite solid earnings beats, Blueprint Medicines is trading down ~16% since my last article ... particularly in systemic mastocytosis treatment. ...CEO Haviland pegged [Blueprint's approved ...
The Baird analyst said that bezuclastinib data in “systemic mastocytosis was not better ... I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for ...
My fear was, OK, my blood sugars are going to go nuts and I'm going to end up in anaphylaxis again and I'm going to end up in ...
my blood sugars are going to go nuts and I'm going to end up in anaphylaxis again and I'm going to end up in the hospital on a vent. Tammie Largent-Phillips, systemic mastocytosis patient The ...